Schedule 13D ownership disclosure

Biohaven Pharmactl Hldg Co

Security class unavailable · CUSIP: G11196105

Event date: 2018-01-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,273,665
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-18-004005
Form type
SC 13D
Filer
Biohaven Pharmaceutical Holding Co Ltd.
CIK
CIK 1689813
Filed
Jan 25, 2018
Reporting period
Jan 15, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub